Lipid vesicles for skin delivery of drugs: reviewing three decades of research.

Since liposomes were first shown to be of potential value for topical therapy by Mezei and Gulasekharam in 1980, studies continued towards further investigation and development of lipid vesicles as carriers for skin delivery of drugs. Despite this long history of intensive research, lipid vesicles are still considered as a controversial class of dermal and transdermal carriers. Accordingly, this article provides an overview of the development of lipid vesicles for skin delivery of drugs, with special emphasis on recent advances in this field, including the development of deformable liposomes and ethosomes.

[1]  R. Hoffman.  Topical liposome targeting of dyes, melanins, genes, and proteins selectively to hair follicles. , 1998, Journal of drug targeting.

[2]  P. Paronen,et al.  Interaction of liposomes with human skin in vitro--the influence of lipid composition and structure. , 1996, Biochimica et biophysica acta.

[3]  P. Wertz,et al.  Elasticity of vesicles affects hairless mouse skin structure and permeability. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[4]  S. Kitagawa,et al.  Enhanced delivery of retinoic acid to skin by cationic liposomes. , 2006, Chemical & pharmaceutical bulletin.

[5]  Q. Ping,et al.  Lecithin vesicular carriers for transdermal delivery of cyclosporin A. , 2000, International journal of pharmaceutics.

[6]  Adrian C. Williams,et al.  Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes , 2001, The Journal of pharmacy and pharmacology.

[7]  N. Weiner,et al.  FOLLICULAR LIPOSOMAL DELIVERY SYSTEMS , 2002, Journal of liposome research.

[8]  G. Cevc,et al.  Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. , 1992, Biochimica et biophysica acta.

[9]  G. E. El Maghraby,et al.  Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. , 2000, International journal of pharmaceutics.

[10]  G. E. El Maghraby,et al.  Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. , 2000, International journal of pharmaceutics.

[11]  Dinesh Mishra,et al.  Elastic liposomes mediated transcutaneous immunization against Hepatitis B. , 2006, Vaccine.

[12]  Chong-K. Kim,et al.  In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome. , 2004, Biomaterials.

[13]  T. Hwang,et al.  Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. , 2006, International journal of pharmaceutics.

[14]  M. L. González-Rodríguez,et al.  Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. , 2005, International journal of pharmaceutics.

[15]  W. Stolz,et al.  Interaction of liposomes with human epidermis reconstructed in vitro , 1995, The British journal of dermatology.

[16]  B. Godin,et al.  Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[17]  N. Weiner,et al.  Topical application of liposomally entrapped cyclosporin evaluated by in vitro diffusion studies with human skin. , 1991, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[18]  E. Touitou,et al.  Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. , 2000, Biomaterials.

[19]  J. Ring,et al.  Improved risk–benefit ratio for topical triamcinolone acetonide in Transfersome® in comparison with equipotent cream and ointment: a randomized controlled trial , 2003, The British journal of dermatology.

[20]  O. Abdallah,et al.  Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. , 2007, Die Pharmazie.

[21]  C. Ramachandran,et al.  Topical delivery of liposomally encapsulated interferon evaluated by in vitro diffusion studies , 1990, Antimicrobial Agents and Chemotherapy.

[22]  F. Bonte,et al.  Cutaneous bioavailability in hairless rats of tretinoin in liposomes or gel. , 1993, Journal of pharmaceutical sciences.

[23]  E. Eliav,et al.  A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[24]  G. Cevc,et al.  Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. , 2004, Biochimica et biophysica acta.

[25]  N. Weiner,et al.  Topical delivery enhancement with multilamellar liposomes into pilosebaceous units: I. In vitro evaluation using fluorescent techniques with the hamster ear model. , 1992, The Journal of investigative dermatology.

[26]  G. Cevc,et al.  New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. , 2001, Biochimica et biophysica acta.

[27]  O. Katare,et al.  The pilosebaceous unit: a pivotal route for topical drug delivery. , 2000, Methods and findings in experimental and clinical pharmacology.

[28]  J. Dubois,et al.  Percutaneous absorption of a new antiandrogen included in liposomes or in solution , 1995 .

[29]  H E Junginger,et al.  Application of vesicles to rat skin in vivo: a confocal laser scanning microscopy study. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[30]  H. Junginger,et al.  Interactions between liposomes and human skin in vitro, a confocal laser scanning microscopy study. , 1998, Biochimica et biophysica acta.

[31]  B. Godin,et al.  Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[32]  G. Betageri,et al.  Transdermal iontophoretic delivery of enkephalin formulated in liposomes. , 1996, Journal of pharmaceutical sciences.

[33]  C. Rhodes,et al.  Preparation and characterization of liposomes as therapeutic delivery systems: a review. , 1995, Pharmaceutica acta Helvetiae.

[34]  H. Junginger,et al.  Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. , 1999, Biochimica et biophysica acta.

[35]  B. Godin,et al.  Erythromycin ethosomal systems: physicochemical characterization and enhanced antibacterial activity. , 2005, Current drug delivery.

[36]  G. Cevc.  Lipid vesicles and other colloids as drug carriers on the skin. , 2004, Advanced drug delivery reviews.

[37]  N. Weiner,et al.  The influence of in vivo treatment of skin with liposomes on the topical absorption of a hydrophilic and a hydrophobic drug in vitro , 1994 .

[38]  Adrian C. Williams,et al.  Can drug‐bearing liposomes penetrate intact skin? , 2006, The Journal of pharmacy and pharmacology.

[39]  J. Bouwstra,et al.  Skin Penetration and Mechanisms of Action in the Delivery of the D2-Agonist Rotigotine from Surfactant-Based Elastic Vesicle Formulations , 2003, Pharmaceutical Research.

[40]  A. Urtti,et al.  Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[41]  J. Fang,et al.  Transdermal iontophoretic delivery of enoxacin from various liposome-encapsulated formulations. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[42]  N. K. Jain,et al.  Transdermal delivery of a pineal hormone: melatonin via elastic liposomes. , 2006, Biomaterials.

[43]  B. Godin,et al.  Enhanced delivery of drugs into and across the skin by ethosomal carriers , 2000 .

[44]  R. Hoffman,et al.  Topical liposome delivery of molecules to hair follicles in mice. , 1997, Journal of dermatological science.

[45]  M. Kim,et al.  Enhanced transfollicular delivery of adriamycin with a liposome and iontophoresis , 2004, Experimental dermatology.

[46]  Adrian C. Williams,et al.  The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs , 1991 .

[47]  N. Weiner,et al.  The influence of particle size of liposomes on the deposition of drug into skin , 1994 .

[48]  R. Cortesi,et al.  Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study. , 2004, Journal of cosmetic science.

[49]  D. Downing,et al.  Interaction between corneocytes and stratum corneum lipid liposomes in vitro. , 1990, Biochimica et biophysica acta.

[50]  M. Mezei,et al.  Liposomes--a selective drug delivery system for the topical route of administration. Lotion dosage form. , 1980, Life sciences.

[51]  E. Peira,et al.  Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. , 2002, International journal of pharmaceutics.

[52]  E. Peira,et al.  Deformable liposomes for dermal administration of methotrexate. , 2004, International journal of pharmaceutics.

[53]  Hsiu‐Ying Yu,et al.  Triamcinolone permeation from different liposome formulations through rat skin in vitro , 1996 .

[54]  T. Tanino,et al.  Effect of Positively and Negatively Charged Liposomes on Skin Permeation of Drugs , 2001, Journal of drug targeting.

[55]  J. Manosroi,et al.  Stability and transdermal absorption of topical amphotericin B liposome formulations. , 2004, International journal of pharmaceutics.

[56]  M. Foldvari,et al.  Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. , 1990, Journal of microencapsulation.

[57]  A. Urtti,et al.  Liposome-skin interactions and their effects on the skin permeation of drugs. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[58]  Chong-K. Kim,et al.  Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. , 2006, Biomaterials.

[59]  G. Cevc,et al.  Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. , 1992, Anesthesia and analgesia.

[60]  W. Wohlrab,et al.  Penetration kinetics of liposomal hydrocortisone in human skin. , 1987, Dermatologica.

[61]  J. Swarbrick,et al.  Encyclopedia of Pharmaceutical Technology , 2006 .

[62]  A. Fahr,et al.  Particle size of liposomes influences dermal delivery of substances into skin. , 2003, International journal of pharmaceutics.

[63]  M. Fresta,et al.  Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles. , 1996, Journal of drug targeting.

[64]  S. Jain,et al.  Ethosomes : A Novel Vesicular Carrier For Enhanced Transdermal Delivery Of An AntiHIV Agent , 2004 .

[65]  A. Rawat,et al.  Tetanus toxoid‐loaded transfersomes for topical immunization , 2005, The Journal of pharmacy and pharmacology.

[66]  W. Sterry,et al.  Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. , 2006, The Journal of investigative dermatology.

[67]  R. Boinpally,et al.  Lecithin vesicles for topical delivery of diclofenac. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[68]  S. Zellmer,et al.  Interaction of phosphatidylcholine liposomes with the human stratum corneum. , 1995, Biochimica et biophysica acta.

[69]  A. Schätzlein,et al.  Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. , 2002, Biochimica et biophysica acta.

[70]  G. Cevc,et al.  Transdermal immunization with large proteins by means of ultradeformable drug carriers , 1995, European journal of immunology.

[71]  A. Schätzlein,et al.  The skin: a pathway for systemic treatment with patches and lipid-based agent carriers , 1996 .

[72]  G. Cevc,et al.  Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. , 1998, Vaccine.

[73]  M. Fresta,et al.  Corticosteroid dermal delivery with skin-lipid liposomes , 1997 .

[74]  N. Weiner,et al.  Topical delivery of liposomally encapsulated gamma-interferon. , 1992, Antiviral research.

[75]  B. W. Barry,et al.  Novel mechanisms and devices to enable successful transdermal drug delivery. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[76]  G. E. El Maghraby,et al.  Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. , 2004, International journal of pharmaceutics.

[77]  E. A. Nunan,et al.  In Vitro Skin Permeation and Retention of Paromomycin from Liposomes for Topical Treatment of the Cutaneous Leishmaniasis , 2004, Drug development and industrial pharmacy.

[78]  N. Weiner,et al.  Liposomes as a Drug Delivery System , 1989 .

[79]  Q. Ping,et al.  Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier. , 2000, Drug delivery.

[80]  N. Weiner,et al.  Topical delivery of ciclosporin: evaluation of various formulations using in vitro diffusion studies in hairless mouse skin. , 1990, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[81]  N. K. Jain,et al.  Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: Development, characterization, and performance evaluation , 2005, AAPS PharmSciTech.

[82]  M. Mezei,et al.  Liposomes—A selective drug delivery system for the topical route of administration: gel dosage form , 1982, The Journal of pharmacy and pharmacology.

[83]  Sanyog Jain,et al.  Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. , 2005, International journal of pharmaceutics.

[84]  G. Cevc.  Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. , 1996, Critical reviews in therapeutic drug carrier systems.

[85]  C. Puglia,et al.  Evaluation of in‐vivo topical anti‐inflammatory activity of indometacin from liposomal vesicles , 2004, The Journal of pharmacy and pharmacology.

[86]  J. Bouwstra,et al.  Vesicles as a tool for transdermal and dermal delivery. , 2005, Drug discovery today. Technologies.

[87]  R. Boinpally,et al.  Iontophoresis of lecithin vesicles of cyclosporin A. , 2004, International journal of pharmaceutics.

[88]  W. Wohlrab,et al.  The effect of liposomal incorporation of topically applied hydrocortisone on its serum concentration and urinary excretion. , 1989, Dermatologische Monatschrift.

[89]  A. Schätzlein,et al.  TRANSDERMAL DRUG CARRIERS - BASIC PROPERTIES, OPTIMIZATION AND TRANSFER EFFICIENCY IN THE CASE OF EPICUTANEOUSLY APPLIED PEPTIDES , 1995 .

[90]  Adrian C. Williams,et al.  Skin delivery of 5‐fluorouracil from ultradeformable and standard liposomes in‐vitro , 2001, The Journal of pharmacy and pharmacology.

[91]  Adrian C. Williams,et al.  Skin Delivery of Oestradiol from Deformable and Traditiona Liposomes: Mechanistic Studies , 1999, The Journal of pharmacy and pharmacology.

[92]  Andreas G. Schätzlein,et al.  Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. , 1998, Biochimica et biophysica acta.

[93]  G. Cevc,et al.  Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes. , 2003, Biochimica et biophysica acta.

[94]  U. Banakar,et al.  Proliposome-Based Transdermal Delivery of Levonorgestrel , 1997, Journal of biomaterials applications.

[95]  N. Yata,et al.  Enhancement of topical delivery of a lipophilic drug from charged multilamellar liposomes. , 1999, Journal of drug targeting.

[96]  M. C. Bonner,et al.  Iontophoretic estradiol skin delivery and tritium exchange in ultradeformable liposomes. , 2002, International journal of pharmaceutics.

[97]  J. Bouwstra,et al.  The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[98]  O. Abdallah,et al.  Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. , 2006, International journal of pharmaceutics.

[99]  A. Fahr,et al.  Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[100]  G. Cevc.  Transdermal Drug Delivery of Insulin with Ultradeformable Carriers , 2003, Clinical pharmacokinetics.

[101]  Chong-Kook Kim,et al.  Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. , 2005, Biomaterials.

[102]  M. Foldvari,et al.  Topical Liposomal local Anesthetics: Design, Optimization and Evaluation of Formulations , 1993 .

[103]  N. Weiner,et al.  Targeted delivery to the pilosebaceous unit via liposomes , 1996 .

[104]  M. C. Bonner,et al.  Electrically assisted skin delivery of liposomal estradiol; phospholipid as damage retardant. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[105]  A. Maza,et al.  Liposomes as Alternative Vehicles for Sun Filter Formulations , 2005, Drug delivery.

[106]  J A Bouwstra,et al.  Skin structure and mode of action of vesicles. , 2002, Advanced drug delivery reviews.

[107]  S. Jain,et al.  Transfersomes—A Novel Vesicular Carrier for Enhanced Transdermal Delivery: Development, Characterization, and Performance Evaluation , 2003, Drug development and industrial pharmacy.

[108]  A. Tiwary,et al.  Sustained and targeted delivery of an anti-HIV agent using elastic liposomal formulation: mechanism of action. , 2006, Current drug delivery.

[109]  J. Bouwstra,et al.  The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[110]  C. Shim,et al.  Targeted and sustained delivery of hydrocortisone to normal and stratum corneum-removed skin without enhanced skin absorption using a liposome gel , 1997 .

[111]  M. Y. Kim,et al.  Skin permeation of retinol in Tween 20‐based deformable liposomes: in‐vitro evaluation in human skin and keratinocyte models , 2006, The Journal of pharmacy and pharmacology.

[112]  Cevc,et al.  Non‐uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high‐resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes) , 1998, The British journal of dermatology.

[113]  Marcello Peppi,et al.  Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[114]  H. Junginger,et al.  Interactions between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small angle X‐ray scattering studies , 1995, The British journal of dermatology.

[115]  H. Junginger,et al.  Transdermal Delivery of Pergolide from Surfactant-Based Elastic and Rigid Vesicles: Characterization and in Vitro Transport Studies , 2002, Pharmaceutical Research.

[116]  Massimo Fresta,et al.  Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[117]  E. Touitou,et al.  Testosterone Ethosomes for Enhanced Transdermal Delivery , 2005, Drug delivery.

[118]  N. K. Jain,et al.  Ethinylestradiol‐loaded ultraflexible liposomes: pharmacokinetics and pharmacodynamics , 2006, The Journal of pharmacy and pharmacology.

[119]  H. Maibach,et al.  Liposomes and Niosomes as Topical Drug Delivery Systems , 2005, Skin Pharmacology and Physiology.

[120]  N. Tavakoli,et al.  Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. , 2006, International journal of pharmaceutics.